原材料、特別利益計、全事業営業利益又は全事業営業損失（△） - 医薬品
- 【期間】
| 年度 | 原材料 | 特別利益計 | 全事業営業利益又は全事業営業損失（△） - 医薬品 |
|---|
| 2008/03 | 36.4億 | | 9.51億 | | - | |
| 2009/03 | - | | 0.8億 | -91.6% | - | |
| 2009/12 | - | | 0.74億 | -7.5% | - | |
| 2010/03 | - | | 0.77億 | +4.1% | - | |
| 2010/06 | - | | 0.04億 | -94.8% | - | |
| 2010/09 | - | | 3.42億 | 大幅増 | - | |
| 2010/12 | - | | 3.42億 | ±0% | - | |
| 2011/03 | - | | 5.33億 | +55.8% | - | |
| 2011/09 | - | | 0.77億 | -85.6% | - | |
| 2011/12 | - | | 0.77億 | ±0% | - | |
| 2012/03 | - | | 0.77億 | ±0% | - | |
| 2013/03 | - | | 0 | -100% | - | |
| 2013/09 | - | | 0 | | - | |
| 2013/12 | - | | 0.46億 | | - | |
| 2014/03 | - | | 0.46億 | ±0% | - | |
| 2014/06 | - | | 0.13億 | -71.7% | - | |
| 2014/09 | - | | 0.17億 | +30.8% | - | |
| 2014/12 | - | | 0.18億 | +5.9% | 83.1億 | |
| 2015/03 | - | | 0.18億 | ±0% | 76.3億 | -8.2% |
| 2015/06 | - | | 0.01億 | -94.4% | 24.5億 | -67.9% |
| 2015/09 | - | | 0.01億 | ±0% | 48.1億 | +96.4% |
| 2015/12 | - | | 0.01億 | ±0% | 109億 | +127% |
| 2016/03 | - | | 0.01億 | ±0% | 96.1億 | -11.9% |
| 2016/06 | - | | 3.59億 | 大幅増 | 30.5億 | -68.3% |
| 2016/09 | - | | 3.59億 | ±0% | 40.6億 | +33.3% |
| 2016/12 | - | | 6.7億 | +86.6% | 71.8億 | +76.6% |
| 2017/03 | - | | 6.7億 | ±0% | 76.7億 | +6.9% |
| 2017/06 | - | | 3.09億 | -53.9% | 17.3億 | -77.5% |
| 2017/09 | - | | 3.09億 | ±0% | 38.6億 | +123.8% |
| 2017/12 | - | | 3.19億 | +3.2% | 80.2億 | +107.7% |
| 2018/03 | - | | 3.2億 | +0.3% | 92.1億 | +14.8% |
| 2018/06 | - | | 0 | -100% | 29.3億 | -68.1% |
| 2018/09 | - | | 0.01億 | | 40.2億 | +36.9% |
| 2018/12 | - | | 0.03億 | +200% | 45.3億 | +12.6% |
| 2019/03 | - | | 0.04億 | +33.3% | 54.9億 | +21.3% |
| 2019/06 | - | | 0.27億 | +575% | 19.4億 | -64.7% |
| 2019/09 | - | | 0.28億 | +3.7% | 19.6億 | +1.3% |
| 2019/12 | - | | 9.77億 | 大幅増 | 20.6億 | +4.8% |
| 2020/03 | - | | 22.6億 | +131.7% | 8.99億 | -56.3% |
| 2020/06 | - | | 0.02億 | -99.9% | 17.5億 | +95.1% |
| 2020/09 | - | | 29.4億 | 大幅増 | 18.5億 | +5.6% |
| 2020/12 | - | | 40.8億 | +38.9% | 24.9億 | +34.4% |
| 2021/03 | - | | 40.9億 | +0.1% | 3.55億 | -85.7% |
| 2021/06 | - | | 35.3億 | -13.6% | -0.34億 | 赤転 |
| 2021/09 | - | | 66.3億 | +87.9% | -2.66億 | 赤拡 |
| 2021/12 | - | | 80.1億 | +20.7% | -12.2億 | 赤拡 |
| 2022/03 | - | | 166億 | +107.4% | -26.1億 | 赤拡 |
| 2022/06 | - | | 13.3億 | -92% | -0.95億 | 赤縮 |
| 2022/09 | - | | 41.1億 | +208.2% | -11.1億 | 赤拡 |
| 2022/12 | - | | 68.8億 | +67.3% | -3.25億 | 赤縮 |
| 2023/03 | - | | 131億 | +90.2% | -22.1億 | 赤拡 |
| 2023/06 | - | | 16.4億 | -87.5% | 10.5億 | 黒転 |
| 2023/09 | - | | 40.5億 | +147.5% | 11.3億 | +7.2% |
| 2023/12 | - | | 50.3億 | +24.1% | 28.5億 | +152.6% |
| 2024/03 | - | | 83.5億 | +65.9% | 26.3億 | -7.8% |
| 2024/06 | - | | 28.1億 | -66.3% | - | |
